
KKR has agreed to acquire Integer Holdings Corporation, a medical-device outsourcing company, for approximately $5.7 billion at $127 per share. This offer represents a 51.8% premium over Integer's closing price on April 29, 2026, and a 28.8% premium over the 30-day average price. The acquisition follows a strategic review by Integer's board and an analyst downgrade to "Hold," reflecting expected price stability until deal completion. Meanwhile, an investor rights law firm is investigating the fairness of the price and compliance with securities laws during the sale process.